Welcome to LookChem.com Sign In|Join Free
  • or
L-Leucine, N-[N-[(phenylmethoxy)carbonyl]-L-seryl]-, 2-chloroethyl ester, commonly known as FMOC-L-Leucine-2-chloroethyl ester, is a modified form of the amino acid leucine. It is a derivative of leucine with an added 2-chloroethyl ester functional group, which makes it a valuable reagent in biochemical research and peptide synthesis. L-Leucine, N-[N-[(phenylmethoxy)carbonyl]-L-seryl]-, 2-chloroethyl ester is particularly important in the field of biochemistry and pharmaceutical research for its role in the synthesis of peptides and proteins.

88962-35-0

Post Buying Request

88962-35-0 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

88962-35-0 Usage

Uses

Used in Biochemical Research:
L-Leucine, N-[N-[(phenylmethoxy)carbonyl]-L-seryl]-, 2-chloroethyl ester is used as a reagent in biochemical research for its ability to facilitate the synthesis of peptides and proteins. Its unique structure allows for the efficient incorporation of leucine into peptide chains, making it a valuable tool in the study of protein structure and function.
Used in Solid-Phase Peptide Synthesis:
In the pharmaceutical industry, L-Leucine, N-[N-[(phenylmethoxy)carbonyl]-L-seryl]-, 2-chloroethyl ester is used as a key component in solid-phase peptide synthesis. This technique allows for the stepwise assembly of peptide chains on an insoluble resin support, enabling the production of large quantities of peptides with high purity and yield. The use of L-Leucine, N-[N-[(phenylmethoxy)carbonyl]-L-seryl]-, 2-chloroethyl ester as a protecting group for serine residues ensures the selective deprotection and coupling of amino acids during the synthesis process.
Used in Peptide Drug Development:
L-Leucine, N-[N-[(phenylmethoxy)carbonyl]-L-seryl]-, 2-chloroethyl ester is also utilized in the development of peptide-based drugs. Peptides have emerged as promising therapeutic agents due to their high specificity and potency. The use of L-Leucine, N-[N-[(phenylmethoxy)carbonyl]-L-seryl]-, 2-chloroethyl ester in peptide synthesis allows for the creation of novel peptide drugs with potential applications in various therapeutic areas, such as oncology, immunology, and endocrinology.

Check Digit Verification of cas no

The CAS Registry Mumber 88962-35-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,8,9,6 and 2 respectively; the second part has 2 digits, 3 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 88962-35:
(7*8)+(6*8)+(5*9)+(4*6)+(3*2)+(2*3)+(1*5)=190
190 % 10 = 0
So 88962-35-0 is a valid CAS Registry Number.

88962-35-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name N-Benzyloxycarbonyl-L-seryl-L-leucin-2-chlorethylester

1.2 Other means of identification

Product number -
Other names N-benzyloxycarbonyl-L-seryl-L-leucin-2-chlorethylester

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:88962-35-0 SDS

88962-35-0Relevant academic research and scientific papers

Glycopeptide Synthesis: Selective C-terminal Deblocking and Peptide Chain Elongation of Glucosylserine Derivatives

Buchholz, Michael,Kunz, Horst

, p. 1859 - 1885 (2007/10/02)

Benzyloxycarbonyl-(Z-)serine 2-bromoethyl ester (3b) reacts with 2,3,4,6-tetra-O-benzoyl-α-D-glucopyranosyl bromide (14) to give the glucosylserine ester 15.After conversion into the corresponding 2-iodoethyl ester 23 the carboxylic group is deblocked selectively by reductive elimination using zinc.In this procedure the Z and the carbohydrate protective functions as well as the sensitive O-glycoside bond remain unaffected.The glycosylserine 24 is condensed with amino acid 2-bromoethyl esters 2 to form protected glycodipeptide 2-bromoethyl esters 18 which are extended to give glycotripeptide esters 25 after selective carboxyl deblocking.Whereas protected serine dipeptides 5 are glycosylated with 14 to form the conjugates 18, the glycosylation of the serine tripeptides 10 was not successful.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 88962-35-0